CHI Advisors’s Oncorus, Inc. ONCR Stock Holding History

CHI Advisors’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,367,436	Closed	-$815K	–	30
2023 Q1	$815K	Hold	2,367,436	–	–	0.22%	23
2022 Q4	$600K	Hold	2,367,436	–	–	0.16%	21
2022 Q3	$2.01M	Hold	2,367,436	–	–	0.54%	21
2022 Q2	$2.98M	Sell	2,367,436 -50,000	-2%	-$67.9K	1.14%	18
2022 Q1	$4.3M	Buy	2,417,436 +310,533	+15%	+$870K	1.83%	12
2021 Q4	$11.1M	Buy	2,106,903 +350,924	+20%	+$2.72M	3.69%	8
2021 Q3	$16.4M	Buy	1,755,979 +20,000	+1%	+$228K	4.79%	8
2021 Q2	$24M	Sell	1,735,979 -35,807	-2%	-$553K	5.57%	6
2021 Q1	$24.7M	Buy	1,771,786 +91,880	+5%	+$1.9M	4.94%	6
2020 Q4	$54.3M	Buy	+1,679,906	New	+$38.9M	15.3%	2

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

YAL

Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return

CHI Advisors's ONCR Position: Q2 2023 in Review

CHI Advisors sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 2,367,436 shares — an estimated $815K sold.

CHI Advisors first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $54.3M in Q4 2020. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

CHI Advisors reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
CHI Advisors sold 2,367,436 Oncorus, Inc. shares in Q2 2023, an estimated $815K.
CHI Advisors first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
CHI Advisors's Oncorus, Inc. position peaked at $54.3M in Q4 2020.
4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on CHI Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.